Impact of DOTS and DOTS-plus on multidrug resistant TB: DOTS-plus strengthens, not weakens, DOTS programmes
- 17 July 2003
- Vol. 327 (7407) , 164
- https://doi.org/10.1136/bmj.327.7407.164
Abstract
AcknowledgmentsEAN thanks Donna Barry, Mercedes C Becerra, Arachu Castro, Paul E Farmer, Mary C Smith Fawzi, Rajesh Gupta, Jim Y Kim, Carole Mitnick, Joia S Mukherjee, and Michael L Rich for their contribution to this letter.Keywords
This publication has 5 references indexed in Scilit:
- Impact of DOTS compared with DOTS-plus on multidrug resistant tuberculosis and tuberculosis deaths: decision analysisBMJ, 2003
- Community-Based Therapy for Multidrug-Resistant Tuberculosis in Lima, PeruNew England Journal of Medicine, 2003
- Increasing transparency in partnerships for health – introducing the Green Light CommitteeTropical Medicine & International Health, 2002
- Frequency of recurrence among MDR-tB cases 'successfully' treated with standardised short-course chemotherapy.2002
- Primary multidrug-resistant tuberculosis--Ivanovo Oblast, Russia, 1999.1999